Organization Profile

You just read:

Opdivo™ (nivolumab) shows superior progression-free survival in previously untreated advanced melanoma when given either alone or with Yervoy® (ipilimumab) versus Yervoy alone

News provided by

Bristol-Myers Squibb Canada

Jun 03, 2015, 05:59 ET